NEW YORK (Reuters) -More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs ...

The National Unit for Special Crime (National enhed for Særlig Kriminalitet, NSK) has arrested and charged a former employee of Copenhagen Municipality for using the CPR system to help plan a ...

The US Food and Drug Administration approved, the first rapid-acting interchangeable biosimilar product, Kirsty (insulin ...

Steatotic liver disease often progresses asymptomatically, with the risk of advancing to cirrhosis and liver cancer. Early detection of advanced liver disease through screening presents an opportunity ...

Clever Culture’s APAS is now on trial with Novo Nordisk, and if it delivers, this one machine could unlock a global pharma ...

Weather-wise, it will be a very “Danish” week, according to DMI, with sun, rain, and clouds alternating. Fortunately, the weekend looks like the best part. Here’s a look at this week’s forecast — and ...

The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the ...

An article by Thai business platform ลงทุนแมน, recently shared by the Thai-Swedish Chamber of Commerce, sheds light on what ...

Clever Culture Systems Ltd (ASX: CC5), a leader in AI microbiology automation that provides intelligent automation solutions ...

Europe clinical trials market was valued at valued at $10,939.1 million in 2022 and will grow by 6.4% annually over 2022-2031, driven by the increasing number of clinical trials and increase in demand ...

The pharma major is also strengthening its presence in the central nervous system (CNS) therapeutic area, Vohra stated ...

Novo Nordisk, a leading global healthcare company, is excited to announce a new Memorandum of Understanding with the Saudi ...